Dynavax Technologies
DVAX
#4893
Rank
C$2.55 B
Marketcap
C$21.77
Share price
-0.22%
Change (1 day)
21.45%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: C$2.55 Billion

As of January 2026 Dynavax Technologies has a market cap of C$2.55 Billion. This makes Dynavax Technologies the world's 4893th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026C$2.55 B3.36%
2025C$2.47 B0.86%
2024C$2.45 B2.31%
2023C$2.39 B30.12%
2022C$1.84 B-14.36%
2021C$2.15 B244.02%
2020C$0.62 B-0.22%
2019C$0.62 B-20.03%
2018C$0.78 B-45%
2017C$1.42 B596.61%
2016C$0.20 B-84.13%
2015C$1.28 B150.33%
2014C$0.51 B-6.13%
2013C$0.54 B5.84%
2012C$0.51 B20.97%
2011C$0.42 B15.8%
2010C$0.36 B355.99%
2009C$81.09 M99.24%
2008C$40.7 M-79.92%
2007C$0.20 B-52.25%
2006C$0.42 B265.82%
2005C$0.11 B-48.99%
2004C$0.22 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Dynavax Technologies was reported to be:

C$2.56 Billion
by Nasdaq info icon info icon
C$2.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
C$0.22 B-91.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$34.80 B 1,261.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$380.83 B 14,797.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$212.43 B 8,209.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$413.78 B 16,086.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
C$141.46 B 5,433.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$201.43 B 7,779.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$51.57 B 1,917.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
C$243.94 B 9,442.64%๐Ÿ‡บ๐Ÿ‡ธ USA